Real-life effectiveness and safety of
Glecaprevir/Pibrentasvir in HCV-infected patients
with chronic kidney disease
Reported by Jules Levin
EASL 219 April 10-14 Vienna
M. PERSICO1, A. AGLITTI1, R. CARUSO1, G. CALVANESE1, P. DI SIERVI1, M. MASARONE1
1Department of Medicine and Surgery - Internal Medicine and Hepatology Unit, University of Salerno, Italy
